We have detected that the browser you are using is no longer supported. As a result, some content may not display correctly.
We suggest that you upgrade to the latest version of any of the following browsers:
close notification
The Medicines Control Council (MCC) has approved the first human
clinical trials for a phase 1 HIV vaccine trial in South Africa,
with the use of cutting edge technology.